Search

everythinglearnresearchcommunity

for

Search:↓

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Mesalazine may help treat extensive alopecia areata effectively.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Foam corticosteroid covers as well as traditional forms.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Baricitinib is effective for severe alopecia areata but has some side effects.

Cyclosporine may cause hair loss, so patients need monitoring.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Vitamin A affects hair loss and immune response in alopecia areata.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Four specific genes are linked to keloid formation and could be potential treatment targets.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.